Celltrion's Truxima approved in Australia
SEOUL, April 20 (Yonhap) -- South Korean biopharmaceutical firm Celltrion Inc. said Friday it has won an approval from an Australian regulator for the sale of its biosimilar drug Truxima.
The Therapeutic Goods Administration accepted Celltrion's ap